| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 | LH Labcorp Holdings Inc. | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 324 | $253.90 | $82,263.60 | -4.6% | -10.8% | +4.1% | |
| Feb 3, 2023 | LH Labcorp Holdings Inc. | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sell | 173 | $253.90 | $43,924.70 | -3.1% | -10.8% | +4.1% | |
| Feb 3, 2023 | PGNY Progyny, Inc. | Anevski Peter74 | Chief Executive Officer | Sell | 80,000 | $35.96 | $2,877,000.08 | -5.2% | -6.0% | +9.9% | |
| Feb 3, 2023 | PGNY Progyny, Inc. | Schlanger David J76 | Executive Chairman | Sell | 200,000 | $35.96 | $7,192,472.12 | -36.4% | -6.0% | +9.9% | |
| Feb 3, 2023 | HCA Hca Healthcare, Inc. | Rutherford Bill B48 | CFO And EVP | Sell | 30,000 | $258.19 | $7,745,568.00 | -26.9% | +7.6% | +19.9% | |
| Feb 2, 2023 | MCK McKesson Corp | Tyler Brian S. | Chief Executive Officer | Sell | 7,416 | $380.00 | $2,818,080.00 | -8.9% | -3.3% | +37.6% | |
| Feb 2, 2023 | SGRY Surgery Partners, Inc. | Brittenham Marissa71 | Chief Strategy Officer | Sell | 1,320 | $35.90 | $47,388.00 | -12.5% | +2.3% | -9.8% | |
| Feb 2, 2023 | SGRY Surgery Partners, Inc. | Doherty David T76 | Chief Financial Officer | Sell | 1,947 | $35.90 | $69,897.30 | -3.3% | +2.3% | -9.8% | |
| Feb 2, 2023 | HCA Hca Healthcare, Inc. | Akdamar Erol R | Group President | Sell | 3,000 | $258.63 | $775,891.20 | -8.0% | +7.8% | +19.9% | |
| Feb 2, 2023 | AGL Agilon Health, Inc. | Kornitzer Benjamin69 | Chief Med. &Quality Officer | Sell | 36,178 | $22.80 | $824,980.87 | -63.4% | +4.9% | -73.1% | |
| Feb 1, 2023 | ALHC Alignment Healthcare, Inc. | Kumar Dinesh M.84 | Chief Med &Operating Officer | Sell | 10,000 | $12.19 | $121,921.00 | -0.9% | -45.7% | -48.1% | |
| Feb 1, 2023 | PGNY Progyny, Inc. | Anevski Peter74 | Chief Executive Officer | Sell | 40,919 | $35.14 | $1,437,765.00 | -5.2% | -5.7% | +10.1% | |
| Feb 1, 2023 | PGNY Progyny, Inc. | Schlanger David J76 | Executive Chairman | Sell | 101,285 | $35.18 | $3,562,975.00 | -40.4% | -5.7% | +10.1% | |
| Feb 1, 2023 | HCA Hca Healthcare, Inc. | Paslick P. Martin | SVP And CIO | Sell | 1,000 | $256.95 | $256,948.70 | -25.0% | +7.3% | +20.3% | |
| Feb 1, 2023 | HCA Hca Healthcare, Inc. | Cuffe Michael S.49 | EVP And Chief Clinical Officer | Sell | 4,000 | $257.11 | $1,028,440.40 | -16.1% | +7.3% | +20.3% | |
| Feb 1, 2023 | HCA Hca Healthcare, Inc. | Foster Jon M | EVP And COO | Sell | 16,424 | $251.98 | $4,138,480.10 | -60.0% | +7.3% | +20.3% | |
| Feb 1, 2023 | HCA Hca Healthcare, Inc. | Wyatt Christopher F.48 | SVP &Controller | Sell | 4,900 | $253.30 | $1,241,170.00 | -13.1% | +7.3% | +20.3% | |
| Jan 30, 2023 | HCA Hca Healthcare, Inc. | McManus Timothy M | Group President | Sell | 7,900 | $254.06 | $2,007,067.16 | -22.0% | +12.1% | +19.1% | |
| Jan 23, 2023 | SNDA Sonida Senior Living, Inc. | Ortelius Advisors, L.P. | 10% Owner | Buy | 5,973 | $15.44 | $92,238.25 | +0.4% | -49.6% | -42.0% | |
| Jan 20, 2023 | AGL Agilon Health, Inc. | Kornitzer Benjamin69 | Chief Med. &Quality Officer | Sell | 16,188 | $19.79 | $320,439.30 | -43.7% | +22.1% | -68.8% | |
| Jan 19, 2023 | PNTG Pennant Group, Inc. | Stringfield Joanne61 | - | Sell | 190 | $11.17 | $2,121.35 | -0.7% | +6.2% | +32.9% | |
| Jan 18, 2023 | ALHC Alignment Healthcare, Inc. | Freeman Robert Thomas58 | Chief Financial Officer | Sell | 1,100 | $13.01 | $14,308.03 | -0.2% | -50.7% | -38.3% | |
| Jan 18, 2023 | ALHC Alignment Healthcare, Inc. | Kumar Dinesh M.84 | Chief Med &Operating Officer | Sell | 1,125 | $13.01 | $14,632.99 | -0.1% | -50.7% | -38.3% | |
| Jan 18, 2023 | ALHC Alignment Healthcare, Inc. | Kao John E68 | Chief Executive Officer | Sell | 1,100 | $13.01 | $14,310.01 | - | -50.7% | -38.3% | |
| Jan 18, 2023 | ENSG Ensign Group, Inc | Snapper Suzanne D.45 | CFO | Sell | 20,393 | $95.85 | $1,954,573.73 | -4.6% | +4.8% | +23.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.